The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Mar. 21, 2022
Applicant:
Shine-on Biomedical Co., Ltd., Taichung, TW;
Inventors:
Der-Yang Cho, Taichung, TW;
Shao-Chih Chiu, Taichung, TW;
Shi-Wei Huang, Taichung, TW;
Chih-Ming Pan, Taichung, TW;
Mei-Chih Chen, Taichung, TW;
Yu-Chuan Lin, Taichung, TW;
Yeh Chen, Taichung, TW;
Assignee:
SHINE-ON BIOMEDICAL CO., LTD., Taichung, TW;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2833 (2013.01); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); C07K 16/2827 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/524 (2013.01); C07K 2317/526 (2013.01); C07K 2317/569 (2013.01); C07K 2317/73 (2013.01); C07K 2317/74 (2013.01);
Abstract
The present disclosure provides an immunomodulation and anti-tumor-related nanobody that specifically binds to a human leukocyte antigen-G, a programmed cell death ligand 1, and CD3 ε. The present disclosure also provides the nucleic acid sequence of the immunomodulation and anti-tumor-related nanobody, and use of the immunomodulation and anti-tumor-related nanobody for treating cancer and immune-related disorders.